Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC: Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50:1464–74.PubMedCrossRef 30. Zhang A, Chen G, Meng L, Wang Q, Hu W, Xi L, Gao Q, Wang S, Zhou J, Xu G, Meng L, Ma D: Antisense-Snail transfer inhibits tumor metastasis by inducing E-cadherin expression. Anticancer Res 2008, 28:621–8.PubMed 31. Berx G, Becker KF, Hofler H, van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 2008, 12:226–237.CrossRef 32. Savagner P, Yamada KM, Thiery JP: The zinc-finger protein

slug causes desmosome dissociation, an initial and Lenvatinib clinical trial necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997, 137:1403–1419.PubMedCrossRef 33. Thiery JP: Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002, 2:442–454.PubMedCrossRef 34. Kanai

Y, Ushijima S, Tsuda H, Sakamoto M, Hirohashi S: Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett 2000, 148:73–80.PubMedCrossRef 35. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F: E-Cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995, 14:6107–6115.PubMed 36. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-Cadherin germline mutations in familial gastric cancer. Nature caspase inhibitor (Lond.) 1998, 392:402–405.CrossRef Adenosine triphosphate 37. Risinger JI, Berchuck A, Kohler MF, Boyd J: Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet

1994, 7:98–102.PubMedCrossRef 38. Doyle S, Evans AJ, Rakha EA, Green AR, Ellis IO: Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening. Radiology 2009, 253:51–5.PubMedCrossRef 39. Sarrió D, Palacios J, Hergueta-Redondo M, Gómez-López G, Cano A, Moreno-Bueno G: Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer 2009, 9:74.PubMedCrossRef 40. Ihara A, Koizumi H, Hashizume R, Uchikoshi T: Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 1996, 23:1441–1447.PubMed 41. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, CP-690550 Tiollais P, Buendia MA: Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology 2002, 36:692–701.PubMedCrossRef 42. Endo K, Ueda T, Ueyama J, Ohta T, Terada T: Immunoreactive E-cadherin, α-catenin, β-catenin, and γ-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients’ survival. Hum Pathol 2000, 31:558–565.PubMedCrossRef 43.